CS INSIGHTS BIOTECH MARKET / BUSINESS INTELLIGENCE Sotio 2/5/2021 April 2021 Review of news from the most innovative therapeutic areas and the business development transactions by Jakub Jarolím, Business Intelligence Department SOTIO MARKET The Nasdaq Biotech Index added 4 % during April 2021 The Nasdaq Biotech Index added 4 % during April after a drop experienced in March. The index is however still 10 % below its maximum from February this year. Numerous companies presented their new data during virtual AACR conference. NEWS DETAIL PROSTATE CANCER Nivolumab-ipilimumab combo demonstrated significant antitumor activity in PCA Nivolumab-ipilimumab combination demonstrates antitumor activity in prostate cancer subset. A combination of nivolumab and ipilimumab induced significant antitumor activity among men with metastatic castration-resistant prostate cancer and a positive immunogenic signature, according to results of the phase 2 NEPTUNES trial. NEWS DETAIL OVARIAN CANCER NEWS Merck and Alkermes to evaluate combination of Keytruda with nemvaleukin FDA approved theinitiation of endoxifenstudy in OVCA. A patient with ovarian cancer has begun treatment with oral endoxifen, an active metabolite of tamoxifen, after a Safe to Proceed Letter was granted by the FDA, according to a press release by Atossa Therapeutics. NEWS DETAIL LUNG CANCER NEWS AstraZeneca’s Tagrisso was approved in China for lung cancer treatment AstraZeneca's lung cancer drug approved in China: AstraZeneca said that its Tagrisso medicine has been approved in China for the treatment of early lung cancer. The UK-based pharmaceutical giant said Tagrisso is the first such drug to have received approval in China, as well as the only one to have shown efficacy against the disease in a global trial. NEWS DETAIL ONCOLOGY TRANSACTIONS Precision Bio reacquires global rights to its allogenic CAR-T programs Selected M&As and Partnering NEWS DETAIL DISCLAIMER / SOTIO Legal notice NEWS DETAIL Share on social networks NEWS TO EMAIL Get the latest press releases, interviews, podcasts, and insights. SUBSCRIBE TO NEWS FOLLOW US FOR MEDIA For Media Press Releases Interviews and Podcasts Subscribe To News Downloads Contacts MAY BE OF INTEREST Our Companies Newsroom Insights CONTACTS PPF Group Companies TERMS OF USE DATA PROTECTION SITEMAP COOKIES POLICY COOKIES SETTINGS 2021 © PPF GROUP Cookies Consent We are using cookies for the best experience on our websites. For more information visit our document Information about cookies on the "Cookies settings" menu. By clicking accept all cookies you agree with our use of all the types of cookies. If you want to alter the types of cookies, you can do this in our "Cookies settings" menu. By clicking "Deny cookies" you are refusing all cookies, except cookies necessary for website functionality. Information about cookies Cookies Settings Deny Cookies Accept All Cookies